GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance
Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food...
HealthCares
5 Must-Read Analyst Questions From GE HealthCare’s Q4 Earnings Call
GE HealthCare’s fourth quarter saw positive momentum, with the company surpassing Wall Street’s revenue and non-GAAP profit expectations. Management pointed...
GE HealthCare’s New ECG And AI Imaging Tools Reshape Growth Story
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St....
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark
Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
GE HealthCare’s Allia Moveo gains FDA and CE mark approvals
GE HealthCare’s Allia Moveo system GE HealthCare has announced that its Allia Moveo image-guidance platform has received US Food and...
GE HealthCare’s Q4 2025 Earnings: What to Expect
GE HealthCare Technologies Inc. (GEHC) is a Chicago-based global healthcare technology company that designs, manufactures, and markets advanced medical technologies, diagnostic...
JPM26: GE HealthCare’s CEO maintains disciplined M&A strategy
During his presentation at the ongoing J.P. Morgan Healthcare Conference, GE HealthCare CEO Peter Arduini highlighted that over time, the...
Assessing the Potential Impact in Radiology for GE HealthCare’s Acquisition of Intelerad
Noting longstanding challenges with interoperability in radiology and health care at large, Roland Rott said the brunt of navigating between...
GE HealthCare’s Pristina Recon DL uses deep learning for mammography
GE HealthCare says its Pristina Recon DL technology uses two deep learning models working in sequence for sharper images with fewer...
